Literature DB >> 22697344

Endoplasmic reticulum stress in chronic obstructive lung diseases.

C M P Ribeiro1, W K O'Neal.   

Abstract

Chronic airway inflammation characterizes several airway diseases, including cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). The altered airway milieu that results from the pathogenic processes in these disorders affects the airway epithelia, leading to an up-regulation of their innate defense. In human airway epithelia, luminal inflammatory stimuli induce an adaptation characterized by an expansion of the endoplasmic reticulum (ER) and its Ca(2+) stores. This epithelial adaption mediates Ca(2+)-dependent "hyperinflammatory" responses, and recent studies have shown that activation of the unfolded protein response (UPR) by ER stress is involved in the process. The UPR is also known to be activated by cigarette smoke, the primary trigger for development of COPD. These studies illustrate the functional role of UPR pathways during airway inflammation and suggest that targeting the UPR may be a therapeutic strategy for obstructive airway diseases. This article reviews the link between airway epithelial inflammation and activation of the UPR, and discusses how UPR activation might be relevant for CF and COPD airways disease.

Entities:  

Mesh:

Year:  2012        PMID: 22697344     DOI: 10.2174/156652412801318791

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  28 in total

Review 1.  The UPR and lung disease.

Authors:  Fabiola Osorio; Bart Lambrecht; Sophie Janssens
Journal:  Semin Immunopathol       Date:  2013-03-28       Impact factor: 9.623

Review 2.  Molecular mechanisms of acrolein toxicity: relevance to human disease.

Authors:  Akshata Moghe; Smita Ghare; Bryan Lamoreau; Mohammad Mohammad; Shirish Barve; Craig McClain; Swati Joshi-Barve
Journal:  Toxicol Sci       Date:  2015-02       Impact factor: 4.849

Review 3.  Role of epithelial sodium channels in the regulation of lung fluid homeostasis.

Authors:  Sadis Matalon; Rafal Bartoszewski; James F Collawn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-10-02       Impact factor: 5.464

4.  Flavored e-liquids increase cytoplasmic Ca2+ levels in airway epithelia.

Authors:  Temperance R Rowell; James E Keating; Bryan T Zorn; Gary L Glish; Stephen B Shears; Robert Tarran
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-11-06       Impact factor: 5.464

Review 5.  DAMPs activating innate and adaptive immune responses in COPD.

Authors:  S D Pouwels; I H Heijink; N H T ten Hacken; P Vandenabeele; D V Krysko; M C Nawijn; A J M van Oosterhout
Journal:  Mucosal Immunol       Date:  2013-10-23       Impact factor: 7.313

Review 6.  Nonmicrobial-mediated inflammatory airway diseases--an update.

Authors:  Polani B Ramesh Babu; P Krishnamoorthy
Journal:  J Physiol Biochem       Date:  2013-11-29       Impact factor: 4.158

7.  Bronchial epithelial injury in the context of alloimmunity promotes lymphocytic bronchiolitis through hyaluronan expression.

Authors:  Vandy P Stober; Christopher Szczesniak; Quiana Childress; Rebecca L Heise; Carl Bortner; John W Hollingsworth; Isabel P Neuringer; Scott M Palmer; Stavros Garantziotis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-04-18       Impact factor: 5.464

8.  X-Box-Binding Protein 1 and Innate Immune Responses of Human Cystic Fibrosis Alveolar Macrophages.

Authors:  Bob A Lubamba; Lisa C Jones; Wanda K O'Neal; Richard C Boucher; Carla M P Ribeiro
Journal:  Am J Respir Crit Care Med       Date:  2015-12-15       Impact factor: 21.405

Review 9.  Endoplasmic reticulum stress in drug- and environmental toxicant-induced liver toxicity.

Authors:  Si Chen; William B Melchior; Lei Guo
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2014       Impact factor: 3.781

Review 10.  Cigarette smoke and CFTR: implications in the pathogenesis of COPD.

Authors:  Andras Rab; Steven M Rowe; S Vamsee Raju; Zsuzsa Bebok; Sadis Matalon; James F Collawn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-08-09       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.